The Company has initiated shipments for both the retail and the medical professional markets into the Kingdom.
'We are proud to announce another step for our Company in introducing the pain relief and healing benefits of ActiPatch to the international market. We are working closely with Distinction Corporation and excited to include them in our growing list of distributors. I have every confidence that this new relationship will bring not only success to our two companies in the Kingdom of Jordan, but also additional expansion into other Middles East markets,' said Andrew Whelan, President of BioElectronics Corporation.
Farid Tamini, President of Distinction Corporation, said, 'With the approval process behind us, we will quickly launch this wonderful product in the Kingdom of Jordan. We are pleased to be working with BioElectronics. There is an air of enthusiasm for this unique drug free therapy that will surely multiply as the medical professionals and patients experience the benefits of ActiPatch.'
ActiPatch granted market clearance by the Food & Drug Administration in the Kingdom of Jordan
BioElectronics Corporation announced that the Jordan Food & Drug Administration has cleared ActiPatch for sale.
- Jordan: Thursday, November 15 - 2007 at 10:16
- PRESS RELEASE
 |
related stories |
- ADD ARTICLE TO
-
Facebook
del.icio.us
Digg
Index : Company News : BioElectronics Corporation
Browse related articles
Browse related articlesToday's most read articles:
Most read articles the past week:
Log in to request more information from BioElectronics CorporationNotes and media contacts
About BioElectronics:BioElectronics Corporation is the maker of ActiPatch. ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
Safe Harbor Statement:
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
CONTACT: Andrew J. Whelan, President & CEO of BioElectronics
Corporation, 1-866-757-2284, Fax: +1-301-874-6935.
Posted by Anne-Birte Stensgaard, Senior News EditorThursday, November 15 - 2007 at 10:16 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AME Info Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AME Info Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AME Info Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AME Info Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
Web Feeds